hotspot -WSS

hotspot

author：leisure time 2025-09-06 03:17:27 - browse：414

A Medicare health insurance card on top of several hundred-dollar bills, with Benjamin Franklin's eyes covered by pills. — Adobe

The public will soon find out whether the federal government is willing to meet the health insurance industry’s demands and deposit more money into the bank accounts of next year’s Medicare Advantage plans.

Budget officials within the Biden administration started reviewing final payment regulations for 2025 Medicare Advantage plans last week after more than 42,000 public comments rolled into the federal government’s inbox. Those rules will come out no later than April 1.

In February, the government proposed a modest cut to next year’s average benchmark payment for Medicare Advantage plans, which are privately run insurance policies that now cover more than 33 million Americans. However, insurers are still estimated to receive more money under the proposal, overall, due to the aggressive way they code the medical conditions of their members.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： AstraZeneca loses challenge to Medicare drug price negotiation

explore

WSS

FDA endorses new sterilization method for medical devices

Medicare bonuses could stop drug shortages under Senate plan

FDA endorses new sterilization method for medical devices

Medicare drug price lawsuits could be good politics for Biden

Inaction leaves children at risk from dangerous chemotherapy drug

House looks to weaken Medicare negotiation

Wikipedia

hotspot

focus

Drug repurposing or repositioning? The language matters

Medicare drug price lawsuits could be good politics for Biden

Hepatitis C has a cure — but many Americans still lack access to it

Medicare drug price lawsuits could be good politics for Biden

Supreme Court strikes down use of affirmative action

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Alkermes shareholders re

Flu vaccine offering decent levels of protection this winter, new data show

At least 13 dead in Texas as scorching temps continue

CVS is on a mission to consolidate health care. Will it work?

hotspot

RSV vaccines may be linked to small increased risk of developing GBS

Maisha Meds is a PBM, but don't call it that

An inside look at PIPEs, biotech's buzzy new financing tool

Medicare bonuses could stop drug shortages under Senate plan

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

focus

explore

focus

explore